Gamma-delta T-cell receptor complex (γδ TCR complex)

The gamma-delta (γδ) T-cell receptor (TCR) signaling complex is a specialized molecular assembly on the surface of γδ T cells, a distinct lineage of lymphocytes that integrate innate and adaptive immune functions [1, 3]. This complex is composed of a heterodimeric TCR (consisting of γ and δ glycoprotein chains) non-covalently associated with CD3 signaling subunits, including epsilon, delta, gamma, and zeta [4, 9]. Unlike conventional alpha-beta (αβ) T cells, γδ T cells recognize antigens—such as phosphoantigens, lipids, and stress-induced proteins—independently of the major histocompatibility complex (MHC), allowing for rapid, broad-spectrum immune responses [3, 10]. In the context of disease, the γδ TCR complex plays a critical role in immunosurveillance against various cancers and infections, though its dysregulation is also implicated in certain autoimmune conditions and T-cell lymphomas [7, 11, 16]. Therapeutically, the complex is targeted by bispecific antibodies, phosphoantigen agonists, and engineered cell therapies designed to trigger the potent cytotoxic and pro-inflammatory activities of γδ T cells against malignant cells [13, 15]. These approaches are particularly valued for their potential to provide "off-the-shelf" treatments with a lower risk of graft-versus-host disease compared to αβ T-cell-based therapies [12, 13].

Other names

γδ TCRTCR gamma-delta complexGamma-delta T-cell receptor-CD3 complexT-cell receptor gamma-delta

Agonism and activation of γδ T cells leading to cytokine release and direct cytotoxicity against target cells [10, 13].